Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (64)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cumming, R. G.
Right arrow Articles by Mitchell, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cumming, R. G.
Right arrow Articles by Mitchell, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 145, No. 3: 242-249
Copyright © 1997 by The Johns Hopkins University School of Hygiene and Public Health


research-article

Hormone Replacement Therapy, Reproductive Factors, and Cataract The Blue Mountains Eye Study

Robert G. Cumming1 and Paul Mitchell2

1Department of Public Health and Community Medicine, Univer-srty of Sydney Sydney, Australia
2Department of Ophthalmology, Westmead Hospttal, University of Sydney Sydney, Australia

Reprint requests to Dr Robert G Cumming, Department of Public Health and Community Medicine, Building A27, University of Sydney, Sydney NSW 2006, Australia.

The relation between estrogen (endogenous and exogenous) and cataract is unclear, with one large population-based study recently suggesting a protective effect of estrogen replacement therapy. The study reported in this paper, the Blue Mountains Eye Study, was conducted in Australia in 1992–1993 and involved 2, 072 women aged 49–97 years. Subjects were recruited from a defined geographic area; the participation rate was 83 percent. Eye examination included photographs of the lens, which were graded for presence and seventy of cortical, nuclear, and posterior subcapsular cataracts. Later age at menarche was associated with increased prevalence of all three types of cataract, but there were no associations with age at menopause, number of children, or use of the oral contraceptive pill. Among all women, there was no association between hormone replacement therapy and cataract. However, current users of hormone replacement therapy aged 65 years and over, among whom the duration of use was likely to have been longer than in younger current users, had lower prevalence of cortical cataract than did never users, the odds ratio adjusted for numerous potential confounders was 0 4 (95 percent confidence interval 0.2–0 8). The prevalence of posterior subcapsular cataract was increased in current users of hormone replacement therapy who had a nonsurgical menopause; the adjusted odds ratio was 2.1 (95 percent confidence interval 1 1–4.1). The results of this study support the hypothesis that estrogen and/or progestin may be involved in cataract development. The effect of hormone replacement therapy on the lens needs to be evaluated in the laboratory and in further observational epidemiologic studies. Am J Epidemiol 1997; 145: 242-9.

cataract; estrogen replacement therapy, menarche; menopause; risk factors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
R. M. Bigsby, S. Valluri, J. Lopez, M. S. Mendonca, A. Caperell-Grant, C. DesRosiers, and J. R. Dynlacht
Ovarian Hormone Modulation of Radiation-Induced Cataractogenesis: Dose-Response Studies
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3304 - 3310.
[Abstract] [Full Text] [PDF]


Home page
Asia Pac J Public HealthHome page
N.H. Noran, N. Salleh, and M. Zahari
Relationship between Reproductive Exposures and Age-Related Cataract in Women
Asia Pac J Public Health, June 1, 2007; 19(2): 23 - 28.
[Abstract] [PDF]


Home page
Arch OphthalmolHome page
M. N. Haan, R. Klein, B. E. Klein, Y. Deng, L. K. Blythe, J. M. Seddon, D. C. Musch, L. H. Kuller, L. G. Hyman, and R. B. Wallace
Hormone Therapy and Age-Related Macular Degeneration: The Women's Health Initiative Sight Exam Study
Arch Ophthalmol, July 1, 2006; 124(7): 988 - 992.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
V. Dumeaux, J. Johansen, A.-L. Borresen-Dale, and E. Lund
Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy.
Mol. Cancer Ther., April 1, 2006; 5(4): 868 - 876.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
B. N. Mukesh, A. Le, P. N. Dimitrov, S. Ahmed, H. R. Taylor, and C. A. McCarty
Development of Cataract and Associated Risk Factors: The Visual Impairment Project
Arch Ophthalmol, January 1, 2006; 124(1): 79 - 85.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. K. Nirmalan, J. Katz, A. L. Robin, R. Ramakrishnan, R. Krishnadas, R. D. Thulasiraj, and J. M. Tielsch
Female Reproductive Factors and Eye Disease in a Rural South Indian Population: The Aravind Comprehensive Eye Survey
Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4273 - 4276.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
A J Lee, P Mitchell, E Rochtchina, and P R Healey
Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study
Br J Ophthalmol, November 1, 2003; 87(11): 1324 - 1328.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Wang, J. W. Simpkins, J. A. Dykens, and P. R. Cammarata
Oxidative Damage to Human Lens Epithelial Cells in Culture: Estrogen Protection of Mitochondrial Potential, ATP, and Cell Viability
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2067 - 2075.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. E. Marin-Castano, S. J. Elliot, M. Potier, M. Karl, L. J. Striker, G. E. Striker, K. G. Csaky, and S. W. Cousins
Regulation of Estrogen Receptors and MMP-2 Expression by Estrogens in Human Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 50 - 59.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. L. Davis, C.-C. Chan, T. J. Schoen, J. F. Couse, G. J. Chader, and K. S. Korach
An estrogen receptor repressor induces cataract formation in transgenic mice
PNAS, July 9, 2002; 99(14): 9427 - 9432.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. Younan, P. Mitchell, R. G. Cumming, J. Panchapakesan, E. Rochtchina, and A. M. Hales
Hormone Replacement Therapy, Reproductive Factors, and the Incidence of Cataract and Cataract Surgery: : The Blue Mountains Eye Study
Am. J. Epidemiol., June 1, 2002; 155(11): 997 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
D C Minassian, V Mehra, and A Reidy
Childbearing and risk of cataract in young women: an epidemiological study in central India
Br J Ophthalmol, May 1, 2002; 86(5): 548 - 550.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. E. Freeman, B. Munoz, O. D. Schein, and S. K. West
Hormone Replacement Therapy and Lens Opacities: The Salisbury Eye Evaluation Project
Arch Ophthalmol, November 1, 2001; 119(11): 1687 - 1692.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Congdon, S. K. West, R. R. Buhrmann, A. Kouzis, B. Munoz, and H. Mkocha
Prevalence of the Different Types of Age-Related Cataract in an African Population
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2478 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
C. Munaut, V. Lambert, A. Noel, F. Frankenne, M. Deprez, J.-M. Foidart, and J.-M. Rakic
Presence of oestrogen receptor type {beta} in human retina
Br J Ophthalmol, July 1, 2001; 85(7): 877 - 882.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. Worzala, R. Hiller, R. D. Sperduto, K. Mutalik, J. M. Murabito, M. Moskowitz, R. B. D'Agostino, and P. W. F. Wilson
Postmenopausal Estrogen Use, Type of Menopause, and Lens Opacities: The Framingham Studies
Arch Intern Med, June 11, 2001; 161(11): 1448 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
N. G Congdon
Prevention strategies for age related cataract: present limitations and future possibilities
Br J Ophthalmol, May 1, 2001; 85(5): 516 - 520.
[Full Text]


Home page
Arch OphthalmolHome page
B. E. K. Klein
Reflections on Sex-Related Risk of Eye Disease
Arch Ophthalmol, March 1, 2001; 119(3): 428 - 429.
[Full Text] [PDF]


Home page
IOVSHome page
A. M. Hales, C. G. Chamberlain, and J. W. McAvoy
Susceptibility to TGF{beta}2-Induced Cataract Increases with Aging in the Rat
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3544 - 3551.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
S. C Bourke and H. Clague
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines
Postgrad. Med. J., October 1, 2000; 76(900): 618 - 624.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. M. Bigsby, H. Cardenas, A. Caperell-Grant, and C. J. Grubbs
Protective effects of estrogen in a rat model of age-related cataracts
PNAS, August 3, 1999; 96(16): 9328 - 9332.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. B. Ogueta, S. D. Schwartz, C. K. Yamashita, and D. B. Farber
Estrogen Receptor in the Human Eye: Influence of Gender and Age on Gene Expression
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1906 - 1911.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. Wensor, C. A. McCarty, and H. R. Taylor
Prevalence and Risk Factors of Myopia in Victoria, Australia
Arch Ophthalmol, May 1, 1999; 117(5): 658 - 663.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
M P Vessey, P Hannaford, J Mant, R Painter, P Frith, and D Chappel
Oral contraception and eye disease: findings in two large cohort studies
Br J Ophthalmol, May 1, 1998; 82(5): 538 - 542.
[Abstract] [Full Text]


Home page
Br J OphthalmolHome page
G. DUNCAN, I M. WORMSTONE, and P. D DAVIES
The aging human lens: structure, growth, and physiological behaviour
Br J Ophthalmol, October 1, 1997; 81(10): 818 - 823.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.